Polymeric in situ forming depots have emerged as highly promising drug delivery systems
for long-acting applications. Their effectiveness is attributed to essential characteristics such …

Owing to the variety and complexity of ocular diseases and the natural ocular barriers, drug
therapy for ocular diseases has significant limitations, such as poor drug targeting to the site …

Ocular drug delivery is a challenging field due to the unique anatomical and physiological
barriers of the eye. Biodegradable polymers have emerged as promising tools for efficient …

The complex nature of the ocular drug delivery barrier presents a significant challenge to the
effective administration of drugs, resulting in poor therapeutic outcomes. To address this …

Ophthalmic disease can cause permanent loss of vision and blindness. Easy-to-administer
topical and systemic treatments are preferred for treating sight-threatening disorders. Typical …

Bacterial keratitis is a major cause of blindness, hindered by the rising threat of antibiotic
resistance. Although corneal bandage lenses (CBLs) are widely utilized in ophthalmic …

The fabrication of an effective in situ gelling ophthalmic drug delivery vehicle is recently
received enormous interest to overcome the demerits of conventional ocular solutions and …

Optimal vision remains one of the most essential elements of the sensory system
continuously threatened by many ocular pathologies. Various pharmacological agents …

Bacteria‐induced keratitis is a major cause of corneal blindness in both developed and
developing countries. Instillation of antibiotic eyedrops is the most common management of …

This study aimed at formulating the antiglaucoma agent, Bimatoprost (BMT), into niosomal in
situ gel (BMT-ISG) for ocular delivery. Niosomes containing cholesterol/span 60 entrapping …